Pterygia: Pathogenesis and the Role of Subconjunctival Bevacizumab in Treatment

ISSN： 0882-0538

Source： Seminars in Ophthalmology, Vol.24, Iss.3, 2009-05, pp. : 130-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Primary and Recurrent Pterygia

By Shepard Dennis Riegel Byron W. Lyon Christopher Davis David B. Duffin R. Michael Suslov Tamara C. Weinman Tay J. Fabricant Robert N. Beeve Jerrold

Annals of Ophthalmology, Vol. 34, Iss. 3, 2002-09 ,pp. : 178-182

Humana Press, Inc

Access to resources Recommend Favorite

Prevention and Treatment of Corneal Neovascularization: Comparison of Different Doses of Subconjunctival Bevacizumab with Corticosteroid in Experimental Rats

Ophthalmic Research, Vol. 42, Iss. 2, 2009-06 ,pp. : 90-95

Karger

Access to resources Recommend Favorite

Preliminary Results of Subconjunctival Bevacizumab in Primary Pterygium Excision

Ophthalmic Research, Vol. 43, Iss. 3, 2009-10 ,pp. : 134-138

Karger

Access to resources Recommend Favorite

The Anti-inflammatory Effect of Subconjunctival Bevacizumab on Chemically Burned Rat Corneas

By Oh Joo Youn Kim Mee Kum Shin Mi Sun Lee Hyun Ju Lee Jin Hak Wee Won Ryang

Current Eye Research, Vol. 34, Iss. 2, 2009-02 ,pp. : 85-91

Informa Healthcare

Access to resources Recommend Favorite

Effect of Subconjunctival and Intraocular Bevacizumab Injections on Corneal Neovascularization in a Mouse Model

By Avisar Inbal Weinberger Dov Kremer Israel

Current Eye Research, Vol. 35, Iss. 2, 2010-02 ,pp. : 108-115

Informa Healthcare

Access to resources Recommend Favorite